Another form of subgroup to beware

Radiotherapy and Oncology

Volumn 101, Issue 3, 2011, Pages 525-526

  Denham, James W ^a   Lamb, David S ^b   Joseph, David ^c   Matthews, John ^d   Atkinson, Chris ^e   Spry, Nigel A ^c   Duchesne, Gillian ^f   Ebert, Martin ^c   Steigler, Allison ^a   D'Este, Catherine ^g  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b WELLINGTON HOSPITAL   (New Zealand)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

^e St Georges Cancer Care Centre   (New Zealand)

^f PETER MACCALLUM CANCER CENTRE   (Australia)

^g UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CANCER MORTALITY; CLINICAL EFFECTIVENESS; HUMAN; ILLNESS TRAJECTORY; LETTER; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT OUTCOME; TREATMENT RESPONSE;

HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 81855166638     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.08.032     Document Type: Letter

References (2)

1. M.-P. Sylvestre, E. Huszti, and J.A. Hanley Do Oscar winners live longer than less successful peers? A reanalysis of the evidence Ann Intern Med 145 2006 361 363
2. J.W. Denham, D.S. Lamb, and D. Joseph PSA response signatures - a powerful new prognostic indicator after radiation for prostate cancer? Radiother Oncol 90 2009 382 388